During the past decade, Hospital de Jerez conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 16 clinical trials were completed, i.e. on average, 22.5% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 10 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Jerez" #1 sponsor was "PETHEMA Foundation" with 18 trials, followed by "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 9 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Spanish Breast Cancer Research Group" with 7 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Jerez" #1 collaborator was "Hoffmann-La Roche" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Spanish Network for Research in Infectious Diseases" with 3 trials as a collaborator, "Apices Soluciones S.L." with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Jerez" are "Multiple Myeloma" (6 trials), "Breast Cancer" (5 trials), "Acute Lymphoblastic Leukemia" (4 trials), "Advanced Prostate Cancer" (4 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Hospital de Jerez" in a lesser frequency.

Most popular intervention types in "Hospital de Jerez" are "Drug" (87 trials), "Procedure" (9 trials), "Biological" (8 trials), "Other" (8 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dexamethasone" (7 trials), "Prednisone" (7 trials), "Cyclophosphamide" (6 trials) and "Bortezomib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Jerez" are 102 trials for "All" genders, 12 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Jerez". 3 are not yet recruiting, 26 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Hospital de Jerez, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Jerez, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 4 trials that are defined as “Not Applicable".